Thalidomide for refractory gastrointestinal bleeding from vascular malformations in patients with significant comorbidities

BACKGROUND: Refractory gastrointestinal bleeding (GIB) secondary to gastrointestinal vascular malformations (GIVM) such as gastrointestinal angiodysplasia (GIAD) and gastric antral vascular ectasia (GAVE) remains challenging to treat when endoscopic therapy fails. Recently thalidomide has been sugge...

Descripción completa

Detalles Bibliográficos
Autores principales: Bayudan, Alexis Mae, Chen, Chien-Huan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2020
Materias:
Retrospective Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7441260/
https://www.ncbi.nlm.nih.gov/pubmed/32874976
http://dx.doi.org/10.12998/wjcc.v8.i15.3218

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7441260/
https://www.ncbi.nlm.nih.gov/pubmed/32874976
http://dx.doi.org/10.12998/wjcc.v8.i15.3218

Ejemplares similares